跳至主要内容
临床试验/JPRN-UMIN000016441
JPRN-UMIN000016441已完成1 期

Dose-escalation Study of Afatinib in Elderly Patients with EGFR mutation for Non-Small Cell Lung Cancer - Dose-escalation Study of Afatinib in Elderly Patients with EGFR mutation for Non-Small Cell Lung Cancer

Hirosaki University Graduate School of Medicine0 个研究点目标入组 18 人开始时间: 2015年2月4日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
75years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Having severe complications 2)Symptomatic brain metastases 3)Interstitial pneumonitis on chest Xray 4)Past history of severe allergic reactions to drugs 5)Pregnant or breastfeeding woman 6)Receiving steroids or immunosuppressants 7)Active infectious disease 8)Uncontrollable pleural effusion or pericardial effusion 9)Active double cancer 10)Patients whose physicians considered as inappropriate for this clinical study

研究者

发起方
Hirosaki University Graduate School of Medicine

相似试验